Proton Pump Inhibitor MDL Motion Denied By Federal Judicial Panel
(February 2, 2017, 1:54 PM EST) -- WASHINGTON, D.C. — A federal judicial panel on Feb. 2 denied a motion to centralize 39 federal lawsuits alleging kidney injury from proton pump inhibitor (PPI) drugs because they involve four...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login